Molina Healthcare, Inc $MOH Shares Newly Bought by AlphaGrep UK Ltd

AlphaGrep UK Ltd acquired a new stake in Molina Healthcare, Inc (NYSE:MOH – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 3,927 shares of the company’s stock, valued at approximately $743,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MOH. BlackRock Inc. purchased a new stake in Molina Healthcare in the 2nd quarter valued at $1,503,052,000. Manning & Napier Advisors LLC acquired a new position in shares of Molina Healthcare during the 2nd quarter valued at about $152,339,000. Maverick Capital Ltd. acquired a new position in shares of Molina Healthcare during the 1st quarter valued at about $86,081,000. Bank of New York Mellon Corp acquired a new position in shares of Molina Healthcare during the 2nd quarter valued at about $86,138,000. Finally, Bank of America Corp DE purchased a new stake in shares of Molina Healthcare in the second quarter valued at about $71,480,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

Insider Buying and Selling at Molina Healthcare

In other news, Director Richard Schapiro sold 782 shares of the company’s stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $203.94, for a total transaction of $159,481.08. Following the sale, the director owned 11,833 shares of the company’s stock, valued at approximately $2,413,222.02. This represents a 6.20% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Dale Wolf sold 1,600 shares of the stock in a transaction on Friday, November 13th. The shares were sold at an average price of $206.12, for a total value of $329,792.00. Following the completion of the sale, the director owned 14,337 shares in the company, valued at approximately $2,955,142.44. The trade was a 10.04% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 11,084 shares of company stock worth $2,273,419. 1.44% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

MOH has been the subject of several recent analyst reports. Zacks Research cut shares of Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 12th. Weiss Ratings upgraded shares of Molina Healthcare from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, October 21st. Jefferies Financial Group reissued a “hold” rating and issued a $220.00 price target on shares of Molina Healthcare in a research note on Friday, October 23rd. UBS Group raised their price target on shares of Molina Healthcare from $202.00 to $225.00 and gave the stock a “neutral” rating in a report on Friday, October 23rd. Finally, Barclays reduced their price target on shares of Molina Healthcare from $180.00 to $178.00 and set an “underweight” rating on the stock in a research report on Friday, October 23rd. Three research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $213.88.

Check Out Our Latest Research Report on Molina Healthcare

Molina Healthcare Stock Performance

Shares of Molina Healthcare stock opened at $198.66 on Friday. The stock has a market capitalization of $10.37 billion, a price-to-earnings ratio of -206.94, a price-to-earnings-growth ratio of 11.70 and a beta of 0.75. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.69 and a quick ratio of 1.69. The business has a 50-day moving average of $203.94 and a 200 day moving average of $186.45. Molina Healthcare, Inc has a 12 month low of $121.06 and a 12 month high of $244.89.

Molina Healthcare (NYSE:MOH – Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The company reported $0.89 earnings per share for the quarter, beating analysts’ consensus estimates of $0.79 by $0.10. Molina Healthcare had a negative net margin of 0.11% and a positive return on equity of 2.50%. The firm had revenue of $11.08 billion during the quarter, compared to analysts’ expectations of $10.86 billion. During the same quarter in the previous year, the business posted $1.84 earnings per share. The business’s quarterly revenue was down 3.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Molina Healthcare, Inc will post 5.30 earnings per share for the current year.

Molina Healthcare Profile

(Free Report)

Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.

Further Reading

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.